Aardvark Therapeutics(AARD),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

AARD Aardvark Therapeutics

Not Yet Opened 03-12 16:00:00 EDT

5.26

+0.06

+1.15%

盘后5.26

+0.000.00%

18:24 EDT

High5.44	Low5.10	Vol283.96K
Open5.25	D1 Closing5.20	Amplitude6.54%
Mkt Cap114.13M	Tradable Cap30.97M	Total Shares21.70M
T/O1.50M	T/O Rate4.82%	Tradable Shares5.89M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"AARD","market":"US","secType":"STK","nameCN":"Aardvark Therapeutics","latestPrice":5.26,"timestamp":1773345600000,"preClose":5.2,"halted":0,"volume":283962,"hourTrading":{"tag":"盘后","latestPrice":5.26,"preClose":5.26,"latestTime":"18:24 EDT","volume":286,"amount":1516.06,"timestamp":1773354248038,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.011538461538461463,"floatShares":5888000,"shares":21696893,"eps":-2.243,"marketStatus":"Not Yet Opened","change":0.06,"latestTime":"03-12 16:00:00 EDT","open":5.25,"high":5.44,"low":5.1,"amount":1501869.906684,"amplitude":0.065385,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-2.243,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1773388800000},"marketStatusCode":0,"adr":0,"listingDate":1739509200000,"exchange":"NASDAQ","adjPreClose":5.2,"preHourTrading":{"tag":"盘前","latestPrice":5.35,"preClose":5.2,"latestTime":"09:29 EDT","volume":512,"amount":2745.69984,"timestamp":1773322197334,"change":0.15,"changeRate":0.028846,"amplitude":0.0025},"postHourTrading":{"tag":"盘后","latestPrice":5.26,"preClose":5.26,"latestTime":"18:24 EDT","volume":286,"amount":1516.06,"timestamp":1773354248038,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.570305,"impliedVol":1.6909,"impliedVolPercentile":0.9143},"requestUrl":"/m/hq/s/AARD/tweets","defaultTab":"tweets","newsList":[{"id":"2616355111","title":"Schall Law Firm Investigates Aardvark Therapeutics for Securities Law Violations","url":"https://stock-news.laohu8.com/highlight/detail?id=2616355111","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616355111?lang=en_us&edition=fundamental","pubTime":"2026-03-04 23:21","pubTimestamp":1772637694,"startTime":"0","endTime":"0","summary":"The Schall Law Firm has opened an investigation into potential securities law violations by Aardvark Therapeutics Inc. following reports that the company paused a late-stage trial for a rare disease treatment after detecting heart-related side effects in a safety monitoring study involving higher-than-planned doses. Aardvark shares fell more than 47% in after-hours trading on the day of the report.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260304:nNDL8WM2Km:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014005.SGD","IE00B3QW5Z07.USD","IE00B64PRP62.GBP","IE00BGHQF748.EUR","SG9999014039.USD","IE00BKPKM429.USD","LU2095319765.USD","LU2210149790.SGD","SG9999014013.SGD","BK4585","BK4588","AARD","NDAQ","BK4112","SG9999014021.USD","LU2210150020.SGD","LU0314104364.USD"],"gpt_icon":0},{"id":"2616552895","title":"What's Going On With Aardvark Therapeutics Stock On Wednesday?","url":"https://stock-news.laohu8.com/highlight/detail?id=2616552895","media":"Benzinga_recent_news","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616552895?lang=en_us&edition=fundamental","pubTime":"2026-03-04 21:54","pubTimestamp":1772632440,"startTime":"0","endTime":"0","summary":"Aardvark Therapeutics pauses Phase 3 HERO trial after cardiac safety observations, sending shares down nearly 61%.","market":"us","thumbnail":"https://cdn.benzinga.com/files/images/story/2026/03/04/Pipette-Adding-Fluid-To-One-Of-Several-T.jpeg?optimize=medium&dpr=2&auto=webp&width=240","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2026/03/04/Pipette-Adding-Fluid-To-One-Of-Several-T.jpeg?optimize=medium&dpr=2&auto=webp&width=240"],"rights":{"source":"benzinga_recent_news","url":"https://www.benzinga.com/news/health-care/26/03/51033235/whats-going-on-with-aardvark-therapeutics-stock-on-wednesday","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/health-care/26/03/51033235/whats-going-on-with-aardvark-therapeutics-stock-on-wednesday","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_recent_news","symbols":["BK4217","AARD","SMA"],"gpt_icon":0},{"id":"2616536317","title":"Top Midday Decliners","url":"https://stock-news.laohu8.com/highlight/detail?id=2616536317","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616536317?lang=en_us&edition=fundamental","pubTime":"2026-03-03 03:31","pubTimestamp":1772479865,"startTime":"0","endTime":"0","summary":"Aardvark Therapeutics  said late Friday it paused its phase 3 trial of ARD-101 for hyperphagia in patients with Prader-Willi Syndrome after reversible cardiac observations at above target therapeutic doses were found during routine safety monitoring in a healthy volunteer study.RBC downgraded the stock to sector perform from outperform. Other downgrades include HC Wainwright to neutral from buy.Shares sank 56% Monday, with intraday trading volume of over 2.24 million against a daily average of about 191,000.uniQure  shares tumbled 32% after the US Food and Drug Administration said data from the company's phase 1/2 trials was not sufficient to provide the primary evidence of effectiveness needed to support a marketing application for AMT-130, an investigational gene therapy for Huntington's disease.More than 13.7 million shares traded intraday, compared with a daily average of about 2.64 million.Price: 5.46, Change: -7.03, Percent Change: -56.29","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","LU0320765992.SGD","AARD","QURE","LU0109394709.USD","LU0889565916.HKD"],"gpt_icon":0},{"id":"2616338330","title":"Aardvark Therapeutics Inc. : Oppenheimer Cuts Target Price to $21 From $35","url":"https://stock-news.laohu8.com/highlight/detail?id=2616338330","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616338330?lang=en_us&edition=fundamental","pubTime":"2026-03-02 21:37","pubTimestamp":1772458648,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260302:nAZN4SJ5BS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["AARD"],"gpt_icon":0},{"id":"2616337074","title":"BUZZ-Street View: Aardvark slides after pausing late-stage trial; multiple analysts cut PT","url":"https://stock-news.laohu8.com/highlight/detail?id=2616337074","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616337074?lang=en_us&edition=fundamental","pubTime":"2026-03-02 21:32","pubTimestamp":1772458379,"startTime":"0","endTime":"0","summary":"BUZZ-Street View: Aardvark slides after pausing late-stage trial; multiple analysts cut PTMarch 2 (Reuters) - ** Aardvark Therapeutics AARD.O on Friday voluntarily paused a late-stage trial testing it","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260302:nL4N3ZQ151:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AARD"],"gpt_icon":0},{"id":"2616175337","title":"Aardvark Therapeutics Shares Fall 54% Premarket After Pausing Late-Stage Rare Disease Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2616175337","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616175337?lang=en_us&edition=fundamental","pubTime":"2026-03-02 21:22","pubTimestamp":1772457725,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260302:nL4N3ZQ1B4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["AARD"],"gpt_icon":0},{"id":"2616332459","title":"Stifel Nicolaus Downgrades Aardvark Therapeutics to Hold From Buy, Adjusts PT to $6 From $24","url":"https://stock-news.laohu8.com/highlight/detail?id=2616332459","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616332459?lang=en_us&edition=fundamental","pubTime":"2026-03-02 20:39","pubTimestamp":1772455181,"startTime":"0","endTime":"0","summary":"Stifel Nicolaus Downgrades Aardvark Therapeutics to Hold From Buy, Adjusts PT to $6 From $24","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["SF","AARD"],"gpt_icon":0},{"id":"2616331734","title":"Why Is Aardvark Therapeutics Stock Sinking Monday?","url":"https://stock-news.laohu8.com/highlight/detail?id=2616331734","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616331734?lang=en_us&edition=fundamental","pubTime":"2026-03-02 20:02","pubTimestamp":1772452920,"startTime":"0","endTime":"0","summary":"Aardvark Therapeutics Inc.  shares are down during Monday’s premarket session following the company’s announcement to voluntarily pause its Phase 3 HERO trial for Prader-Willi Syndrome.The decision comes as the company is conducting a comprehensive review of safety data.The company on Friday revealed that it will not announce topline data from the HERO trial as previously anticipated in the third quarter of 2026. This pause was prompted by reversible cardiac observations at higher than target therapeutic doses found during routine safety monitoring in a healthy volunteer study.Aardvark’s CEO, Tien Lee, emphasized the commitment to patient safety and the importance of evaluating the signals seen at elevated doses of ARD-101. The company plans to continue collaborating closely with the FDA and the Prader-Willi Syndrome community while determining the next steps for its clinical program.“Assuming resolution of the cardiac safety event, Aardvark may be able to accelerate and streamline the","market":"us","thumbnail":"https://cdn.benzinga.com/files/images/story/2026/03/02/Genetic-Research-And-Biotech-Science-Con.jpeg?optimize=medium&dpr=2&auto=webp&width=630","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2026/03/02/Genetic-Research-And-Biotech-Science-Con.jpeg?optimize=medium&dpr=2&auto=webp&width=630"],"rights":{"source":"benzinga_hot_news","url":"https://www.benzinga.com/news/health-care/26/03/50960206/why-is-aardvark-therapeutics-stock-sinking-monday","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/health-care/26/03/50960206/why-is-aardvark-therapeutics-stock-sinking-monday","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_hot_news","symbols":["AARD"],"gpt_icon":0},{"id":"2616904339","title":"Aardvark Therapeutics Inc : Stifel Cuts to Hold From Buy; Cuts Target Price to $6 From $24","url":"https://stock-news.laohu8.com/highlight/detail?id=2616904339","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616904339?lang=en_us&edition=fundamental","pubTime":"2026-03-02 19:58","pubTimestamp":1772452687,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260302:nFWN3ZQ0XU:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["AARD"],"gpt_icon":0},{"id":"2616315103","title":"RBC Downgrades Aardvark Therapeutics to Sector Perform From Outperform, Cuts Price Target to $6 From $18, Keeps Speculative Risk","url":"https://stock-news.laohu8.com/highlight/detail?id=2616315103","media":"MT Newswires Live","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616315103?lang=en_us&edition=fundamental","pubTime":"2026-03-02 19:52","pubTimestamp":1772452323,"startTime":"0","endTime":"0","summary":"Aardvark Therapeutics (AARD) has an average rating of overweight and mean price target of $24.45, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research f","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["AARD"],"gpt_icon":0},{"id":"2616366863","title":"Aardvark Therapeutics Cut to Equal-Weight From Overweight by Morgan Stanley","url":"https://stock-news.laohu8.com/highlight/detail?id=2616366863","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616366863?lang=en_us&edition=fundamental","pubTime":"2026-03-02 19:31","pubTimestamp":1772451060,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/AARD/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 02, 2026 06:31 ET (11:31 GMT)","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AARD"],"gpt_icon":0},{"id":"2616335746","title":"Aardvark Therapeutics downgraded to Neutral from Buy at H.C. Wainwright","url":"https://stock-news.laohu8.com/highlight/detail?id=2616335746","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616335746?lang=en_us&edition=fundamental","pubTime":"2026-03-02 19:15","pubTimestamp":1772450149,"startTime":"0","endTime":"0","summary":"H.C. Wainwright analyst Raghuram Selvaraju downgraded Aardvark Therapeutics (AARD) to Neutral from Buy without a price target The ARD-101 pivotal P...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/aardvark-therapeutics-downgraded-to-neutral-from-buy-at-h-c-wainwright-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/aardvark-therapeutics-downgraded-to-neutral-from-buy-at-h-c-wainwright-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AARD"],"gpt_icon":0},{"id":"2616335183","title":"Aardvark Therapeutics, Inc. : H.c. Wainwright Cuts to Neutral From Buy","url":"https://stock-news.laohu8.com/highlight/detail?id=2616335183","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616335183?lang=en_us&edition=fundamental","pubTime":"2026-03-02 19:13","pubTimestamp":1772450012,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260302:nAZN4SJ4I9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["AARD"],"gpt_icon":0},{"id":"2616333175","title":"Aardvark Therapeutics Cut to Sector Perform From Outperform by RBC Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2616333175","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616333175?lang=en_us&edition=fundamental","pubTime":"2026-03-02 18:47","pubTimestamp":1772448420,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/AARD/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 02, 2026 05:47 ET (10:47 GMT)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AARD"],"gpt_icon":0},{"id":"2616338410","title":"Stock Market Today: S&P 500, Dow Jones Futures Slide Amid War Against Iran— AMTD Digital, Aardvark, MongoDB In Focus","url":"https://stock-news.laohu8.com/highlight/detail?id=2616338410","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616338410?lang=en_us&edition=fundamental","pubTime":"2026-03-02 18:23","pubTimestamp":1772447038,"startTime":"0","endTime":"0","summary":"U.S. stock futures fell sharply on Monday following Friday’s losses. Futures of the major benchmark indices were negative amid the ongoing Iran-U.S. conflict.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/markets/equities/26/03/50958308/stock-market-today-sp-500-dow-jones-futures-slide-amid-war-against-iran-amtd-digital-aardvark-mongodb-in-focus","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","LU2272731782.SGD","BK4608","BK4559","LU0082616367.USD","LU0719512351.SGD","SPYM","SPXU","SSO","LU0823434740.USD","OEF","MDBX","BK4205","BK4581","LBGJ","LU2357305700.SGD","BK4561","SPDN","LU1923623000.USD","LU0390134368.USD","MESmain","BK4534","BK4607","GPIX","XDTE","SDS","IVV","FAZ","LU1720051017.SGD","SH","BK4161","LU1720051108.HKD","SPLV","LU0823434583.USD","BK4550","SPXL","LU0353189763.USD","SPXS","LU1861220033.SGD","SPYV","BK4116","ESmain","LU2087625088.SGD","SKRE","BK4526","SG9999000418.SGD","SHV","MDB","LU0154245673.USD","LU0353189680.USD","BK4585","BK4023","SPYI","IVW","BIL","HIBL","UPRO","LU2286300806.USD","AARD","LU0154245756.USD","HKD","IVOO","LU1548497426.USD","BK4593","ALBT","OEX","LU1951198990.SGD","VOOV","BK4613","LU2272731600.USD","LU1992135472.HKD","LU1861215975.USD","BK4233","BK4504","LU1992135399.USD","BMAY","TMF","VTI","LU1951200564.SGD"],"gpt_icon":0},{"id":"2616338469","title":"Aardvark downgraded to Equal Weight from Overweight at Morgan Stanley","url":"https://stock-news.laohu8.com/highlight/detail?id=2616338469","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616338469?lang=en_us&edition=fundamental","pubTime":"2026-03-02 18:00","pubTimestamp":1772445625,"startTime":"0","endTime":"0","summary":"Morgan Stanley downgraded Aardvark Therapeutics (AARD) to Equal Weight from Overweight with a price target of $7, down from $29. The emergence of A...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/aardvark-downgraded-to-equal-weight-from-overweight-at-morgan-stanley-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/aardvark-downgraded-to-equal-weight-from-overweight-at-morgan-stanley-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1791710582.SGD","LU1244550221.USD","LU1668664300.SGD","LU1989772840.SGD","LU0314104364.USD","LU1244550577.SGD","LU0795875086.SGD","LU2133065610.SGD","LU0882574139.USD","BK4516","LU1732799900.SGD","BK4588","LU1074936037.SGD","BK4127","LU0106831901.USD","LU0158827781.USD","LU0267386448.USD","LU0912757837.SGD","LU2347655156.SGD","LU0158827948.USD","LU2089284900.SGD","AARD","LU2111349929.HKD","LU0098860793.USD","LU0234570918.USD","BK4504","LU0225283273.USD","LU2028103732.USD","LU2357305700.SGD","LU1989772923.USD","LU1720051108.HKD","LU0557290698.USD","LU0795875169.SGD","LU1363072403.SGD","LU2089283258.USD","LU1720051017.SGD","IE00BZ1G4Q59.USD","LU2023251221.USD","LU0320765646.SGD","LU0006306889.USD","LU0528227936.USD","BK4585","LU0971096721.USD","LU1244550494.USD","LU1732800096.USD","LU1548497426.USD","LU1791710400.SGD","LU1162221912.USD","LU2271345857.HKD","BK4534"],"gpt_icon":0},{"id":"2616385438","title":"U.S. RESEARCH ROUNDUP-Aardvark Therapeutics, Chevron, CrowdStrike","url":"https://stock-news.laohu8.com/highlight/detail?id=2616385438","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616385438?lang=en_us&edition=fundamental","pubTime":"2026-03-02 15:29","pubTimestamp":1772436556,"startTime":"0","endTime":"0","summary":"U.S. RESEARCH ROUNDUP-Aardvark Therapeutics, Chevron, CrowdStrikeMarch 2 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260302:nL4N3ZQ0J1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BURL","AARD","AZZ","LU1551013342.USD","LU2430703251.USD","IRON","LU2324357040.USD","ARRY","AROC","TGT","AVGW","LNG","CRI","AVGO","AVGG","OWL","BOBS","CBT","COR","CME","TCPC","ACVA","AVS","BX","WHD","ADSK","CRWD","AVGX","CAH","CPNG","AEP","ACMR","CRWL","CVX","AVGU","BTSG","COLD","CMC","AVL","ASND","COP","TXG","CTVA","CASY","APO","DORM","ARES","AES","BBWI","ACLX"],"gpt_icon":1},{"id":"2616580790","title":"Aardvark Therapeutics Inc : RBC Cuts to Sector Perform From Outperform; Cuts Target Price to $6 From $18","url":"https://stock-news.laohu8.com/highlight/detail?id=2616580790","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616580790?lang=en_us&edition=fundamental","pubTime":"2026-03-02 13:50","pubTimestamp":1772430621,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260302:nFWN3ZQ08S:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["AARD"],"gpt_icon":0},{"id":"2616806325","title":"Aardvark Therapeutics downgraded to Hold from Buy at Stifel","url":"https://stock-news.laohu8.com/highlight/detail?id=2616806325","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616806325?lang=en_us&edition=fundamental","pubTime":"2026-03-02 10:15","pubTimestamp":1772417705,"startTime":"0","endTime":"0","summary":"Stifel downgraded Aardvark Therapeutics (AARD) to Hold from Buy with a price target of $6, down from $24. The company voluntarily paused its Phase ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/aardvark-therapeutics-downgraded-to-hold-from-buy-at-stifel-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/aardvark-therapeutics-downgraded-to-hold-from-buy-at-stifel-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AARD","SF"],"gpt_icon":0},{"id":"2614689344","title":"Stocks to Watch: Aardvark Therapeutics, Blue Moon Metals","url":"https://stock-news.laohu8.com/highlight/detail?id=2614689344","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614689344?lang=en_us&edition=fundamental","pubTime":"2026-02-28 07:38","pubTimestamp":1772235480,"startTime":"0","endTime":"0","summary":"Aardvark Therapeutics is voluntarily pausing a trial after finding safety issues. Shares slumped 54% to $5.75 in after-hours trading Friday.Blue Moon Metals plans to acquire a Utah mine from Teck Resources. Shares rose 5.9% to $5.41 after closing up 17%.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AARD"],"gpt_icon":0}],"profile":{"websiteUrl":"http://aardvarktherapeutics.com","stockEarnings":[{"period":"1week","weight":-0.0836},{"period":"1month","weight":-0.5829},{"period":"3month","weight":-0.6355},{"period":"6month","weight":-0.3877},{"period":"1year","weight":-0.4813},{"period":"ytd","weight":-0.5992}],"compareEarnings":[{"period":"1week","weight":-0.0224},{"period":"1month","weight":-0.0377},{"period":"3month","weight":-0.023},{"period":"6month","weight":0.0132},{"period":"1year","weight":0.1918},{"period":"ytd","weight":-0.0233}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"exchange":"NASDAQ","name":"Aardvark Therapeutics","nameEN":"Aardvark Therapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Aardvark Therapeutics(AARD),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Aardvark Therapeutics(AARD) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Aardvark Therapeutics,AARD,Aardvark Therapeutics股票,Aardvark Therapeutics股票老虎,Aardvark Therapeutics股票老虎国际,Aardvark Therapeutics行情,Aardvark Therapeutics股票行情,Aardvark Therapeutics股价,Aardvark Therapeutics股市,Aardvark Therapeutics股票价格,Aardvark Therapeutics股票交易,Aardvark Therapeutics股票购买,Aardvark Therapeutics股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Aardvark Therapeutics(AARD),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Aardvark Therapeutics(AARD) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction